Serum levels of CA19-9 may be as an indicator for metastases in patients with non-small cell lung cancer

2011 
Objective The aim of our study was to evaluate the serum levels of CA19-9 in patients with non-small cell lung cancer (NSCLC) and to analyze the relationship between serum levels of CA19-9 and metastasis.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    6
    References
    0
    Citations
    NaN
    KQI
    []